EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C44H61N7O11 |
| Net Charge | 0 |
| Average Mass | 864.010 |
| Monoisotopic Mass | 863.44291 |
| SMILES | CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)O |
| InChI | InChI=1S/C44H61N7O11/c1-5-26(4)37(44(61)62)49-40(57)34-14-10-22-51(34)43(60)31(19-20-35(53)54)46-41(58)36(25(2)3)48-38(55)32(24-27-11-7-6-8-12-27)47-39(56)33-13-9-21-50(33)42(59)30(45)23-28-15-17-29(52)18-16-28/h6-8,11-12,15-18,25-26,30-34,36-37,52H,5,9-10,13-14,19-24,45H2,1-4H3,(H,46,58)(H,47,56)(H,48,55)(H,49,57)(H,53,54)(H,61,62)/t26-,30-,31-,32-,33-,34-,36-,37-/m0/s1 |
| InChIKey | ADBHAJDGVKLXHK-LMXUZNBISA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | delta-opioid receptor antagonist Any compound that exhibits antagonist activity at the δ-opioid receptor. human metabolite Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). EC 3.4.21.36 (pancreatic elastase) inhibitor An EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the activity of pancreatic elastase (EC 3.4.21.36). serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. mu-opioid receptor antagonist Any compound that exhibits antagonist activity at the μ-opioid receptor |
| Applications: | delta-opioid receptor antagonist Any compound that exhibits antagonist activity at the δ-opioid receptor. serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. mu-opioid receptor antagonist Any compound that exhibits antagonist activity at the μ-opioid receptor |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| β-casomorphin-7 (human) (CHEBI:149635) has role EC 3.4.21.36 (pancreatic elastase) inhibitor (CHEBI:149639) |
| β-casomorphin-7 (human) (CHEBI:149635) has role human metabolite (CHEBI:77746) |
| β-casomorphin-7 (human) (CHEBI:149635) has role serotonergic antagonist (CHEBI:48279) |
| β-casomorphin-7 (human) (CHEBI:149635) has role δ-opioid receptor antagonist (CHEBI:59283) |
| β-casomorphin-7 (human) (CHEBI:149635) has role μ-opioid receptor antagonist (CHEBI:50137) |
| β-casomorphin-7 (human) (CHEBI:149635) is a oligopeptide (CHEBI:25676) |
| β-casomorphin-7 (human) (CHEBI:149635) is conjugate acid of β-casomorphin-7 (human)(1−) (CHEBI:147390) |
| Incoming Relation(s) |
| β-casomorphin-7 (human)(1−) (CHEBI:147390) is conjugate base of β-casomorphin-7 (human) (CHEBI:149635) |
| IUPAC Name |
|---|
| L-tyrosyl-L-prolyl-L-phenylalanyl-L-valyl-L-α-glutamyl-L-prolyl-L-isoleucine |
| Synonyms | Source |
|---|---|
| H-Tyr-Pro-Phe-Val-Glu-Pro-Ile-OH | ChEBI |
| human β-casomorphin (1-7) | ChEBI |
| human β-casomorphin-7 | ChEBI |
| NH2-Tyr-Pro-Phe-Val-Glu-Pro-Ile-COOH | ChEBI |
| L-Tyr-L-Pro-L-Phe-L-Val-L-Glu-L-Pro-L-Ile | ChEBI |
| Tyr-Pro-Phe-Val-Glu-Pro-Ile | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| US2010286029 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:102029-74-3 | ChEBI |
| Citations |
|---|